Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02693665 · ClinicalTrials.gov registry record · NA

Building Evidence for Effective Palliative/End of Life Care for Teens With Cancer

A NA study of Cancer, sponsored by Maureen Lyon.

Completed
Registry status
NA
Development phase
260
Enrollment target
4
Study locations

NCT02693665: Completed NA study of Cancer, sponsored by Maureen Lyon.

NCT02693665 is a NA study of Cancer that has completed, run by Maureen Lyon. The registered enrollment target is 260 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (93% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02693665, a NA study of Cancer, has completed, sponsored by Maureen Lyon.

COMPLETED
Registry status
NA
Development phase
260 participants
Enrollment target
4
Study locations

Study Summary

To test the efficacy of FACE-TC on key outcomes, the investigators propose using an intent-to-treat, longitudinal, prospective, multi-site, randomized controlled trial (RCT) design. Adolescents with cancer, aged 14 up to 20 years, and their families (N=130 dyads; N=260 participants) will be recruited and randomized to FACE-TC or Treatment as Usual (TAU) control. Participants will complete standardized questionnaires at baseline and 3, 6, 12, and 18 months post-intervention. Our goal is to assess the extent to which FACE-TC helps adolescents and young adults with cancer and their families: (1) reach and maintain better congruence in treatment preferences over time; (2) improve their quality of life; and (3) document goals of care and advance directives earlier in the course of their potentially life limiting illness.

Conditions Studied

Cancer

Interventions

  • BEHAVIORAL FAmily CEntered Advance Care Planning for Teens with Cancer

Study Locations (4)

District of Columbia

  • Children's National Medical Center - Washington D.C.

Minnesota

  • University of Minnesota Masonic Children's Hospital - Minneapolis

Ohio

  • Akron Children's Hospital - Akron

Tennessee

  • St. Jude Children's Research Hospital - Memphis

Trial Details

FieldValue
Enrollment Target 260 participants
Start Date 2016-07-16
Est. Completion 2022-09-29
Phase NA

Sponsor

Maureen Lyon

5 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02693665

The ClinicalTrials.gov registry entry for NCT02693665 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 260 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (93% lower). The listed sponsor is Maureen Lyon, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which FAmily CEntered Advance Care Planning for Teens with Cancer is the first listed.

NCT02693665 reports 4 study locations spanning 4 distinct geographic areas - top geographies include District of Columbia, Minnesota, Ohio.

Frequently Asked Questions

What is clinical trial NCT02693665 about?

NCT02693665 is a clinical study titled "Building Evidence for Effective Palliative/End of Life Care for Teens With Cancer". To test the efficacy of FACE-TC on key outcomes, the investigators propose using an intent-to-treat, longitudinal, prospective, multi-site, randomized controlled trial (RCT) design. Adolescents with cancer, aged 14 up to 20 years, and their families (N=130 dyads; N=260 participants) will be recruite...

What is the current status of trial NCT02693665?

This trial is currently completed. It is a NA study. The enrollment target is 260 participants. The study started on 2016-07-16. Estimated completion is 2022-09-29.

What conditions does trial NCT02693665 study?

This clinical trial studies the following conditions: Cancer.

What interventions are being tested in trial NCT02693665?

The interventions under investigation include: FAmily CEntered Advance Care Planning for Teens with Cancer (BEHAVIORAL).

Who is sponsoring clinical trial NCT02693665?

This trial is sponsored by Maureen Lyon, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02693665 being conducted?

This trial has 4 study locations across District of Columbia, Minnesota, Ohio, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Cancer

All registered trials for this condition

District of Columbia

All trials with a study site in District of Columbia

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.